Heart Valve Diseases
Conditions
Brief summary
Methods study to evaluate use of cardiac ultrasound to assess heart valve abnormality in people.
Interventions
DEVICEcardiac echosonography
Sponsors
Pfizer
Study design
Observational model
DEFINED_POPULATION
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* \>=18 years of age subjects with stable concomitant diseases with BMI \>=30 kg/m2
Exclusion criteria
* Pregnant females * Those with unstable/new onset diseases * Those who are on agents known to be associated with cardiac valvular heart disease
Countries
United States
Outcome results
None listed